The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Automatic Remote Monitoring of Implantable Cardioverter-Defibrillator Lead and Generator Performance: The Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) Trial
Open accessAbstract
Background—: Monitoring performance of implantable cardioverter-defibrillator (ICD) generators and leads is important. Methods available are with in-person evaluations or by automatic remote home monitoring (HM). These were prospectively evaluated and compared in the TRUST trial. The HM technology tested performed daily self-checks and databasing with rapid event notifications for out-of-range (including asymptomatic) conditions. Methods and Results—: Patients (n=1339) were randomly assigned after ICD implant 2:1 to HM or to conventional groups. Both groups underwent scheduled checks every 3 months and were followed for 15 months. In HM, in-person office visits were scheduled at 3 and 15 months. At 6, 9, and 12 months, HM only was used with subsequent office visits if necessary. Between these time points, ICDs triggered event notifications for system integrity problems. Patients randomly assigned to conventional follow-up were evaluated with office visits only. HM and conventional patients were similar (age, 63.3±12.8 versus 64.0±12.1 years; 72.0% versus 73.1% male; New York Heart Association II class, 55.9% versus 60.4%; left ventricular ejection fraction, 29.0±10.7% versus 28.5±9.8%; coronary artery disease, 64.8% versus 71.7%; primary prevention, 72.2% versus 73.8%; DDD devices, 57.8% versus 56.6%). Four patients crossed over from conventional to HM because of advisories. Scheduled checks were more successfully accomplished in HM (92.7% versus 89.2% in conventional, P <0.001). Sixty-two device-related events (53 in HM versus 9 in conventional) were observed in 46 patients (40 [4.4%] in HM versus 6 [1.39%] in conventional, P =0.004). Forty-seven percent were asymptomatic. HM detected generator and lead problems earlier (HM versus conventional: median, 1 versus 5 days; P =0.05). A total of 20 device problems (eg, lead fracture, elective replacement indicators) requiring surgical revision (0.012 per patient-year) were found, 15 in HM and 5 in the conventional groups. Other events were managed nonsurgically (eg, reprogramming, initiation of antiarrhythmics). Conclusions—: ICD lead and generator malfunction was infrequent and often asymptomatic. Only a minority of detected events required surgical intervention. Automatic HM enhanced discovery, permitted prompt detection, and facilitated management decisions. Longitudinal parameter trending, with component function evaluated daily by remote monitoring, may enable long-term performance assessment. Clinical Trial Registration—: URL: http://clinicaltrials.gov . Unique identifier: NCT00336284.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Self-citationVarma, N., Epstein, A. E., Irimpen, A., Schweikert, R., & Love, C. (2010) · Circulation · doi:10.1161/circulationaha.110.937409 · Cited by 594
Self-citationWilkoff, B. L., Auricchio, A., Brugada, J., Cowie, M., Ellenbogen, K. A., Gillis, A. M., Hayes, D. L., Howlett, J. G., Kautzner, J., Love, C. J., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.04.013 · Cited by 364
Clinical Benefits of Remote Versus Transtelephonic Monitoring of Implanted Pacemakers
Crossley, G. H., Chen, J., Choucair, W., Cohen, T. J., Gohn, D. C., Johnson, W. B., Kennedy, E. E., Mongeon, L. R., Serwer, G. A., Qiao, H., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.001 · Cited by 202
Remote Monitoring of Implantable Cardioverter Defibrillators: A Prospective Analysis
SCHOENFELD, M. H., COMPTON, S. J., MEAD, R. H., WEISS, D. N., SHERFESEE, L., ENGLUND, J., & MONGEON, L. R. (2004) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2004.00524.x · Cited by 194
Carlson, M. D., Wilkoff, B. L., Maisel, W. H., Carlson, M. D., Ellenbogen, K. A., Saxon, L. A., Prystowsky, E. N., Alpert, J. S., Cain, M. E., Ching, E. A., et al. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.08.029 · Cited by 177
Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure
Hauser, R. G., & Hayes, D. L. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.02.024 · Cited by 152
Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines
Maisel, W. H., Hauser, R. G., Hammill, S. C., Hauser, R. G., Ellenbogen, K. A., Epstein, A. E., Hayes, D. L., Alpert, J. S., Berger, R. D., Curtis, A. B., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.04.024 · Cited by 114
Self-citation
Cited by
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
Slotwiner, D., Varma, N., Akar, J. G., Annas, G., Beardsall, M., Fogel, R. I., Galizio, N. O., Glotzer, T. V., Leahy, R. A., Love, C. J., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.008 · Cited by 532
Self-citationVentricular arrhythmias and sudden cardiac death
John, R. M., Tedrow, U. B., Koplan, B. A., Albert, C. M., Epstein, L. M., Sweeney, M. O., Miller, A. L., Michaud, G. F., & Stevenson, W. G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61413-5 · Cited by 286
Leclercq, C., Witt, H., Hindricks, G., Katra, R. P., Albert, D., Belliger, A., Cowie, M. R., Deneke, T., Friedman, P., Haschemi, M., et al. (2022) · EP Europace · doi:10.1093/europace/euac052 · Cited by 109
Telemedicine and cardiac implants: what is the benefit?
Varma, N., & Ricci, R. P. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs388 · Cited by 102
Self-citation
Metadata
- Authors
- Varma, N., Michalski, J., Epstein, A. E., & Schweikert, R.
- Venue
- Circulation: Arrhythmia and Electrophysiology
- Published
- 2010-10
- Volume
- 3
- Issue
- 5
- Pages
- 428-436
- ISSN
- 1941-3084 (ISSN-L)
- 1941-3149
- OpenAlex
- W2626113139
- Cited by
- 162
- References
- 8
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Automatic Remote Monitoring of Implantable Cardioverter-Defibrillator Lead and Generator Performance: The Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) Trial. https://app.cochat.ai/papers/10.1161/circep.110.951962
- The paper
- Varma, N., Michalski, J., Epstein, A. E., & Schweikert, R. (2010). Automatic Remote Monitoring of Implantable Cardioverter-Defibrillator Lead and Generator Performance: The Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) Trial. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.110.951962
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.